Xeris Biopharma Holdings
XERS
XERS
110 hedge funds and large institutions have $102M invested in Xeris Biopharma Holdings in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.88% less ownership
Funds ownership: 40.73% → 39.85% (-0.88%)
30% less capital invested
Capital invested by funds: $147M → $102M (-$44.2M)
Holders
110
Holding in Top 10
2
Calls
$1.73M
Puts
$132K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$863K | |
| 3 | +$772K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$725K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$647K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$3.26M | |
| 3 | -$1.99M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$466K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$403K |